Pathology of Lung Transplantation

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lung transplantation may offer longer survival and improved quality of life to patients with end-stage lung disease. Common indications for single lung transplantation include chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis-, and 1-antitrypsin deficiency emphysema. Bilateral lung transplantation is the norm for cystic fibrosis, but the proportion of bilateral (double) lung transplantation procedures has been rising for other major indications as well. Benchmark survival rates for adult lung transplant recipients are 89% at 3 months, 80% at 1 year, 65% at 3 years, 54% at 5 years, and 31% at 10 years after transplantation. Complications of lung transplantation may be related to (1) the operation itself (primary graft dysfunction, anastomotic complications), (2) the host's immunologic response to the allograft (rejection), and (3) the immunosuppressive therapy used to prevent rejection (infection, posttransplantation lymphoproliferative disorder [PTLD]). Other complications, such as organizing pneumonia and recurrence of the original disease, may also occur. Posttransplantation transbronchial biopsy may be performed for a specific clinical indication or for surveillance of acute rejection. The histopathologic findings most commonly encountered in a posttransplantation transbronchial biopsy include acute rejection, cytomegalovirus infection, airway-centered inflammation, pneumonia, bronchiolitis obliterans, harvest injury, invasive aspergillosis, and PTLD.

Original languageEnglish (US)
Title of host publicationPractical Pulmonary Pathology
Subtitle of host publicationA Diagnostic Approach A Volume in the Pattern Recognition Series
PublisherElsevier
Pages421-437
Number of pages17
ISBN (Electronic)9781455711796
ISBN (Print)9780323442848
DOIs
StatePublished - Oct 20 2017

Fingerprint

Lung Transplantation
Pathology
Lymphoproliferative Disorders
Pneumonia
Primary Graft Dysfunction
Bronchiolitis Obliterans
Biopsy
Benchmarking
Idiopathic Pulmonary Fibrosis
Aspergillosis
Emphysema
Cytomegalovirus Infections
Immunosuppressive Agents
Cystic Fibrosis
Chronic Obstructive Pulmonary Disease
Lung Diseases
Allografts
Survival Rate
Transplantation
Quality of Life

Keywords

  • Bronchiolitis obliterans syndrome
  • Lung
  • Obliterative bronchiolitis
  • Posttransplantation lymphoproliferative disorder
  • Rejection
  • Transplantation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Khoor, A. (2017). Pathology of Lung Transplantation. In Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series (pp. 421-437). Elsevier. https://doi.org/10.1016/B978-0-323-44284-8.00013-2

Pathology of Lung Transplantation. / Khoor, Andras.

Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series. Elsevier, 2017. p. 421-437.

Research output: Chapter in Book/Report/Conference proceedingChapter

Khoor, A 2017, Pathology of Lung Transplantation. in Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series. Elsevier, pp. 421-437. https://doi.org/10.1016/B978-0-323-44284-8.00013-2
Khoor A. Pathology of Lung Transplantation. In Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series. Elsevier. 2017. p. 421-437 https://doi.org/10.1016/B978-0-323-44284-8.00013-2
Khoor, Andras. / Pathology of Lung Transplantation. Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series. Elsevier, 2017. pp. 421-437
@inbook{a8ffdd6c21444cc58ea1a55d41b63e44,
title = "Pathology of Lung Transplantation",
abstract = "Lung transplantation may offer longer survival and improved quality of life to patients with end-stage lung disease. Common indications for single lung transplantation include chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis-, and 1-antitrypsin deficiency emphysema. Bilateral lung transplantation is the norm for cystic fibrosis, but the proportion of bilateral (double) lung transplantation procedures has been rising for other major indications as well. Benchmark survival rates for adult lung transplant recipients are 89{\%} at 3 months, 80{\%} at 1 year, 65{\%} at 3 years, 54{\%} at 5 years, and 31{\%} at 10 years after transplantation. Complications of lung transplantation may be related to (1) the operation itself (primary graft dysfunction, anastomotic complications), (2) the host's immunologic response to the allograft (rejection), and (3) the immunosuppressive therapy used to prevent rejection (infection, posttransplantation lymphoproliferative disorder [PTLD]). Other complications, such as organizing pneumonia and recurrence of the original disease, may also occur. Posttransplantation transbronchial biopsy may be performed for a specific clinical indication or for surveillance of acute rejection. The histopathologic findings most commonly encountered in a posttransplantation transbronchial biopsy include acute rejection, cytomegalovirus infection, airway-centered inflammation, pneumonia, bronchiolitis obliterans, harvest injury, invasive aspergillosis, and PTLD.",
keywords = "Bronchiolitis obliterans syndrome, Lung, Obliterative bronchiolitis, Posttransplantation lymphoproliferative disorder, Rejection, Transplantation",
author = "Andras Khoor",
year = "2017",
month = "10",
day = "20",
doi = "10.1016/B978-0-323-44284-8.00013-2",
language = "English (US)",
isbn = "9780323442848",
pages = "421--437",
booktitle = "Practical Pulmonary Pathology",
publisher = "Elsevier",
address = "Netherlands",

}

TY - CHAP

T1 - Pathology of Lung Transplantation

AU - Khoor, Andras

PY - 2017/10/20

Y1 - 2017/10/20

N2 - Lung transplantation may offer longer survival and improved quality of life to patients with end-stage lung disease. Common indications for single lung transplantation include chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis-, and 1-antitrypsin deficiency emphysema. Bilateral lung transplantation is the norm for cystic fibrosis, but the proportion of bilateral (double) lung transplantation procedures has been rising for other major indications as well. Benchmark survival rates for adult lung transplant recipients are 89% at 3 months, 80% at 1 year, 65% at 3 years, 54% at 5 years, and 31% at 10 years after transplantation. Complications of lung transplantation may be related to (1) the operation itself (primary graft dysfunction, anastomotic complications), (2) the host's immunologic response to the allograft (rejection), and (3) the immunosuppressive therapy used to prevent rejection (infection, posttransplantation lymphoproliferative disorder [PTLD]). Other complications, such as organizing pneumonia and recurrence of the original disease, may also occur. Posttransplantation transbronchial biopsy may be performed for a specific clinical indication or for surveillance of acute rejection. The histopathologic findings most commonly encountered in a posttransplantation transbronchial biopsy include acute rejection, cytomegalovirus infection, airway-centered inflammation, pneumonia, bronchiolitis obliterans, harvest injury, invasive aspergillosis, and PTLD.

AB - Lung transplantation may offer longer survival and improved quality of life to patients with end-stage lung disease. Common indications for single lung transplantation include chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis-, and 1-antitrypsin deficiency emphysema. Bilateral lung transplantation is the norm for cystic fibrosis, but the proportion of bilateral (double) lung transplantation procedures has been rising for other major indications as well. Benchmark survival rates for adult lung transplant recipients are 89% at 3 months, 80% at 1 year, 65% at 3 years, 54% at 5 years, and 31% at 10 years after transplantation. Complications of lung transplantation may be related to (1) the operation itself (primary graft dysfunction, anastomotic complications), (2) the host's immunologic response to the allograft (rejection), and (3) the immunosuppressive therapy used to prevent rejection (infection, posttransplantation lymphoproliferative disorder [PTLD]). Other complications, such as organizing pneumonia and recurrence of the original disease, may also occur. Posttransplantation transbronchial biopsy may be performed for a specific clinical indication or for surveillance of acute rejection. The histopathologic findings most commonly encountered in a posttransplantation transbronchial biopsy include acute rejection, cytomegalovirus infection, airway-centered inflammation, pneumonia, bronchiolitis obliterans, harvest injury, invasive aspergillosis, and PTLD.

KW - Bronchiolitis obliterans syndrome

KW - Lung

KW - Obliterative bronchiolitis

KW - Posttransplantation lymphoproliferative disorder

KW - Rejection

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85054247041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054247041&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-44284-8.00013-2

DO - 10.1016/B978-0-323-44284-8.00013-2

M3 - Chapter

AN - SCOPUS:85054247041

SN - 9780323442848

SP - 421

EP - 437

BT - Practical Pulmonary Pathology

PB - Elsevier

ER -